This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Binggeli, C. Articles by Noll, G. Search for Related Content PubMed PubMed Citation Articles by Binggeli, C. Articles by Noll, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMLODIPINE BESYLATE EPINEPHRINE VERAPAMIL HYDROCHLORIDE Medline Plus Health Information Blood Pressure Medicines High Blood Pressure Related Collections Hypertension - basic studies Clinical Studies Other diagnostic testing Arrhythmias, clinical electrophysiology, drugs

(Hypertension. 2002;39:892.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Effects of Chronic Calcium Channel Blockade on Sympathetic Nerve Activity in Hypertension

Christian Binggeli; Roberto Corti; Isabella Sudano; Thomas F. Luscher; Georg Noll

From the Cardiovascular Center, Division of Cardiology, University Hospital, Zurich, Switzerland.

Correspondence to Georg Noll, MD, FESC, CardioVascular Center, Cardiology, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland. E-mail karnog{at}usz.unizh.ch

The sympathetic nervous system (SNS) is an important regulator of the circulation. Its activity is increased in hypertension and heart failure and adversely affects prognosis. Although certain drugs inhibit SNS, dihydropyridine calcium antagonists may stimulate the system. Phenylalkylamine calcium antagonists such as verapamil have a different pharmacological profile. We therefore tested the hypothesis of whether amlodipine, nifedipine, or verapamil differs in the effects on muscle sympathetic nerve activity (MSA). Forty-three patients (31 men, 12 women) with mild to moderate hypertension were randomly assigned to 1 drug for 8 weeks. Blood pressure, heart rate, and MSA (by microneurography) were measured at baseline and after 8 weeks of treatment. All calcium antagonists led to a similar decrease in blood pressure of 5.0±1.5 to 6.4±1.4 mm Hg at 8 weeks (P<0.001 versus baseline). There were no significant differences in MSA between groups. With amlodipine, MSA averaged 49±3 bursts/min (3 versus baseline); with nifedipine, 48±3 bursts/min (2 versus baseline); and with verapamil, 49±2 bursts/min (all, P=NS). With verapamil, norepinephrine decreased by 4% but tended to increase by about one third with amlodipine or nifedipine (P=NS). Thus, in hypertension slow release forms of verapamil, nifedipine, and amlodipine exert comparable antihypertensive effects and do not change MSA, although there was a trend toward decreased MSA and plasma norepinephrine with verapamil.

Key Words: sympathetic nervous system • calcium antagonists

This article has been cited by other articles:

				B. Gojanovic, F. Feihl, L. Liaudet, and B. Waeber Review: Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2008; 9(1): 1 - 9. [Abstract] [PDF]

				A. Ciarka, B. Najem, N. Cuylits, M. Leeman, O. Xhaet, K. Narkiewicz, M. Antoine, J.-P. Degaute, and P. van de Borne Effects of Peripheral Chemoreceptors Deactivation on Sympathetic Activity in Heart Transplant Recipients Hypertension, May 1, 2005; 45(5): 894 - 900. [Abstract] [Full Text] [PDF]

				M. Hirasawa and Q. J. Pittman From the Cover: Nifedipine facilitates neurotransmitter release independently of calcium channels PNAS, May 13, 2003; 100(10): 6139 - 6144. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, C. Turri, G. Bolla, and G. Mancia Short-Versus Long-Term Effects of Different Dihydropyridines on Sympathetic and Baroreflex Function in Hypertension Hypertension, March 1, 2003; 41(3): 558 - 562. [Abstract] [Full Text] [PDF]